Dr. Rajani explains the reasons we develop a double chin are multi-factorial--but mainly as we…
Kybella in The News – Portland, Oregon
Kybella, an injectable drug, is now the first and only FDA-approved non-surgical treatment for reduction of sub-mental fullness — unattractive double chin.
Oh, that so unattractive double chin! Caused by a number of factors from aging, genetics to weight gain or even weight loss — there is now a new procedure for this “aesthetic condition.” The FDA approved Kybella (deoxycholic acid) for moderate-to-severe adipose tissue below the chin. Kybella, a drug that is injected directly into the chin area where it destroys fat cells, is now the first and only approved non-surgical treatment for reduction of submental fullness.
“Using Kybella for the treatment of fat outside of the submental area is not approved and is not recommended,” the Food and Drug Administration warned in its announcement. Kybella is almost exactly like the deoxycholic acid that is produced in the body to help absorb fats.
The most common side effects of the chin shot include swelling, bruising, pain, numbness, redness, and areas of hardness. Kybella, which is manufactured by Kythera Biopharmaceuticals located in California, also can cause nerve injury in the jaw or destroy skin cells if it is wrongly injected into the skin. Over the course of several years, two clinical trials with 1,022 volunteers established the safety and effectiveness of Kybella.
During a treatment, a patient will be injected directly in their submental fullness up to 50 times. A limit of six such treatments, no less than one month apart, are permissable. Most patients will need any where from 2 to 4 sessions.
For more information on the Kybella Double Chin Shot treatment and/or to schedule a complimentary consult, please call Dr. Rajani at his Portland, Oregon clinic – 503.303.8313 or email firstname.lastname@example.org